Arg-Gly-Glu-Ser |
Catalog No.GC30052 |
Arg-Gly-Glu-Ser는 활성화된 혈소판에 결합하는 피브리노겐에 대한 RGDS 억제 활성에 대한 RGD 관련 펩티드 및 대조군입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 93674-97-6
Sample solution is provided at 25 µL, 10mM.
Arg-Gly-Glu-Ser is a RGD-related peptide and a control for the RGDS ihibitory activity on fibrinogen binding to activated platelets.
Arg-Gly-Glu-Ser (5 mg/kg) in combination with LPS or saline + RGDS does not affect neutrophil and macrophage cell numbers and has no effect on protein accumulation compared with LPS- or saline-treated mice, respectively[1].
[1]. Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10:18.
Average Rating: 5
(Based on Reviews and 37 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *